A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
Clinical trial NCT04544436 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04544436
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-26
- Primary completion
- 2024-12-19
- Enrollment
- 864
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.